Project

New, molecular imaging tests offering improved detection of prostate cancer are changing the management of the disease in ways that are not understood but have the potential for both positive and negative effects on patients and their disease. In this proposal, we aim to understand the effectiveness of molecular imaging tests with the goal of helping patients and prostate cancer stakeholders make more informed clinical decisions that account for the cascade of effects that can be set into motion. To accomplish this, we will generate new evidence relating to the effects of PET imaging in the real-world setting, ultimately integrating this data in a decision model that will generate a clearer picture about the tradeoffs of imaging, including practical scenarios that are most or least likely to benefit patients.